|
Market Cap (4-Jun) $23,964,560 (896th) |
Close (30-Jun) $0.043 |
Volume (30-Jun) 1,415,719 |
Shortsold (5-Nov) 11,657 (0.00%) (566th) |
|
52w High $0.135 |
52w Low $0.043 |
P/E - |
EPS -0.02 |
NOX released this announcement to the ASX on 26 September 2022, 8:56. The announcement is not marked as price sensitive, and is 66 page(s) in length and 2.75MB in size.
You can view all announcements from NOX and see how they appear on a price chart on the announcements page.
At the date of this announcement, NOX was 0.234% short sold according to ASIC data. It was ranked the 416th most shorted stock on the ASX. It remains ranked 566th as of the latest reported data (05 November 2025).
| Other Recent Announcements from NOX | |
|---|---|
| Change of Director's Interest Notice - FB | 29 June 2023, 12:08 |
| Change of Director's Interest Notice - FB | 19 June 2023, 19:08 |
| Change of Director's Interest Notice - BP | 19 June 2023, 19:08 |
| Noxopharm 2022 Annual Report | 26 September 2022, 8:56 |
| Final Director's Interest Notice - GK | 20 September 2022, 18:12 |
| Resignation of Dr Graham Kelly as Non-Executive Director | 19 September 2022, 13:53 |
| Novel Dual-cell Therapy Results in Pancreatic Cancer | 14 September 2022, 8:09 |
You must be logged in to post a reply.
Noxopharm 